Mutations in DNA mismatch repair (MMR) genes in hereditary non-polyposis colon cancer (HNPCC) patients revealed the importance of MMR de®ciency as a risk for carcinogenesis. Since diverse mutations occur in several MMR genes, the instability of repeat sequences dispersed in the genome, which are also governed by the MMR system, is a well used marker. However, the relationship between repeat sequence instability and MMR gene mutation in human cells has not been well de®ned mainly because precise systems to analyse repeat sequences have not been available. Using our newly developed system, we analysed alteration of dinucleotide repeats in human cell lines which harbour mutations in MMR genes. Among 24 subclones of DLD-1 cells (hMSH6 7 ) only one had a dinucleotide repeat alteration in only one microsatellite locus, while LoVo cells (hMSH2 7 /hMSH6 7 ) exhibited marked dinucleotide repeat instability (DRI). HCT116 cells, a hMLH1-mutant, showed an ultimate DRI phenotype. Interestingly, SW48 cells lacking hMLH1 expression also demonstrated DRI, albeit the extent of diversity being signi®cantly lower than HCT116. These data suggest that the DRI phenotype in human cells is highly dependent on mutated MMR genes and on forms of mutation. The results of DRI analyses used to detect MMR-de®ciency should be interpreted with caution.
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Keywords: hMSH2; hMSH6 (GTBP); hMLH1; microsatellite instability; RER In hereditary non-polyposis colon cancer (HNPCC), mutations in genes functioning in DNA mismatch repair (MMR) are inherited in pedigrees highly susceptible to colon cancer (Fishel et al., 1993; Leach et al., 1993; Liu et al., 1994; Nicolaides et al., 1994; Papadopoulos et al., 1994; Parsons et al., 1993) . Eorts have been made to detect MMR-de®cient fractions in human populations, from biological, medical, and social points of view. Among the MMR genes, the hMSH2 or the hMLH1 gene is most frequently mutated in HNPCC patients (Liu et al., 1996; Weber et al., 1997) . However, in many types of sporadic cancers hMSH2 or hMLH1 mutation is rare (Herfarth et al., 1997; Kowalski et al., 1997; Liu et al., 1995; Thibodeau et al., 1996; Wu et al., 1997b) . Moreover, mutations in MMR genes have no marked hot-spots such as ones in the p53 gene (Beck et al., 1997; Liu et al., 1996; Nystrom-Lahti et al., 1996; Weber et al., 1997) and MMR genes sometimes undergo epigenetic silencing (Ahuja et al., 1997) . These ®ndings discouraged attempts to search for mutations in the expanding panel of MMR genes.
Since the MMR system also repairs dinucleotide repeats looping out of the DNA strand, which are caused by slippage of replicational polymerases, alteration of dinucleotide repeats in microsatellite DNA sequences, termed microsatellite instability (MSI) or replication error (RER), has been widely used as a marker to detect MMR-de®ciency. This type of repeat alteration, dinucleotide repeat instability (DRI), was found in 90% of HNPCC patients (Liu et al., 1996; Thibodeau et al., 1993) and in 10 ± 30% in sporadic cancer patients (Ionov et al., 1993; Thibodeau et al., 1993) . These high incidences of DRI phenotype suggest the clinical signi®cance of DRI analysis in assessment of the risk for original or secondary malignancies. However, there are reports of positive DRI cases without mutations in hMSH2 or hMLH1 gene (Herfarth et al., 1997; Kowalski et al., 1997; Liu et al., 1996) . Thus, the relationship between repeat sequence instability and MMR gene mutation in human cells has not been well de®ned. Despite the wide application of DRI analysis, the conventional DRI analysis using polymerase chain reaction (PCR) and autoradiography has left much to be desired regarding PCR conditions, detection characteristics and migration accuracy. Using¯uorescence-labelled PCR and laser scanning, we developed High Resolution Fluorescent Microsatellite Analysis (HRFMA) to detect DRI with a higher accuracy and objectivity (Oda et al., 1997) . In the present study, we used HRFMA to analyse alterations in dinucleotide repeats in human cell lines which harbour mutations in MMR genes and we examined the relationship between DRI and MMR gene mutation. The evidence we obtained showed a distinct dependency of the DRI phenotype on mutated MMR genes and forms of mutation.
Aberrant expression of MMR proteins in human colorectal carcinoma cell lines
We ®rst analysed expression of MMR proteins in human colorectal carcinoma cell lines which harbour mutations in MMR genes and lack MMR activity ( Figure 1A ). In Western blotting analysis using an antihMSH6 antibody, we con®rmed that hMSH6 protein is not expressed in DLD-1 and LoVo cells, as reported elsewhere (Drummond et al., 1995; Palombo et al., 1995; Papadopoulos et al., 1995) . Western blotting with anti-hMSH2 antibody demonstrated two correspond-ing bands, 102 kDa and 100 kDa, in MMR-de®cient cell lines, while 100 kDa polypeptide alone was observed in normal control lines, HT29 and SW620. However, in LoVo cells, reported to be hMSH2-mutant, the 102 kDa polypeptide alone was recognised. Given that the 100 kDa polypeptide is functional, LoVo cells were hMSH2-de®cient.
In Western blotting analyses using anti-hMLH1 ( Figure 1B) , we found that expression of 75 kDa polypeptide corresponding to hMLH1 protein is nil in HCT116 and SW48, although another 60 kDa polypeptide was also detected, speci®cally. HCT116 cells are reported to harbour a nonsense mutation in exon 9 in hMLH1 gene (Branch et al., 1995; Bronner et al., 1994; Papadopoulos et al., 1994) . On the other hand, SW48 cells express no message of the hMLH1 gene in connection with altered distribution of methylated cytosines in the upstream region (Ahuja et al., 1997; Boyer et al., 1995) . We used here an antibody recognising the carboxyl terminus of this protein. Therefore, truncated proteins could be expressed in HCT116 cells, while hMLH1 protein may not exist in SW48 cells. We found no abnormal expression of hPMS1 and hPMS2 proteins in all these cell lines ( Figure 1B ).
DRI in human cell lines lacking MutS homologues
Western blotting analyses of MMR proteins revealed a distinct loss of hMSH6 expression in DLD-1 and LoVo cells, although LoVo has an additional abnormality in the expression of hMSH2. Therefore, we ®rst analysed DRI in these cells using High Resolution Fluorescent Microsatellite Analysis (HRFMA) (Oda et al., 1997) . To observe the diversity of dinucleotide repeats in growing cells, we isolated more than 20 clones from exponentially growing cells using 96-well plates. Genomic DNA extracted from these clones was subjected to HRFMA. Surprisingly, among 24 clones of DLD-1 cells only one had an alteration of dinucleotide repeats in only one locus of the ®ve microsatellite loci analysed (Table 1 ). The DRI phenotype seen in one clone of DLD-1 might be signi®cant, since independently replicating clones of human normal ®broblast cell lines were reported to show no alteration of dinucleotide repeats (Shibata et al., 1994) . Nevertheless, such a low incidence of dinucleotide repeat alteration might not be practical for examinations when searching for the DRI phenotype. On the other hand, in 24 clones of LoVo cells, many types of alterations were observed (Figure 2 ), although no change was detected in two loci, D2S123 and D11S904 (Table 1) . Here we referred to the pro®le that appeared most frequently as`normal (N)' and to pro®les that diered from the`normal' pro®le as`variant (V)'. In D10S197, fourteen types of variants were observed in 24 clones of LoVo cells. LoVo cells did not express hMSH6 and hMSH2 proteins ( Figure 1A ). This marked DRI phenotype may be derived from an hMSH2 mutation, since DLD-1, which is a hMSH6-mutant, exhibited no evident DRI phenotype. In analyses of over 20 clones of normal control lines, HT29 and SW620, no alteration was recognised in all ®ve loci. Thus, there is a distinct dependency of DRI phenotype on mutated MMR genes (Figure 3 ).
DRI phenotype in hMLH1-de®cient cell lines
Next, we analysed DRI in HCT116 and SW48, both of which lack hMLH1 expression as shown in Figure 1B . Sixteen clones of HCT116 and 21 clones of SW48 were analysed by HRFMA, respectively. In HCT116 cells, we noted the ultimate diversity of dinucleotide repeats. In all the loci, over seven types of variants were recognised and in D10S197, all the pro®les derived from 16 clones diered (Table 2 ). SW48 cells also exhibited a marked DRI phenotype, albeit the extent of diversity being relatively low (Table 2) . In four loci, the numbers of variants were fewer than eight, while in D2S123 we detected 14 variants. Thus, there is a close correlation between hMLH1 mutation and the DRI phenotype. Intriguingly, the extent of diversity observed in dinucleotide repeats was signi®cantly dierent between the two hMLH1-mutant cell lines (Figure 3) . In HCT116 cells, aberrant proteins might perturb normal functions of MutL homologue complexes.
Susceptibility to dinucleotide repeat alteration is thought to be highly dependent on the number of repeats, since replicational polymerases might be prone Figure 1 Expression of mismatch repair proteins in human colorectal carcinoma cell lines. Exponentially growing cells were harvested and lysed in Laemmli's SDS sample buer (Laemmli, 1970) . Lysate prepared from 4610 5 cells was subjected to SDSpolyacrylamide (7.5%) gel electrophoresis and proteins were transferred onto nitrocellulose membranes. Western blotting was done as described elsewhere (Nakabeppu et al., 1993) , using rabbit or goat polyclonal antibodies against hMSH2, hMSH6, hMLH1, hPMS1 and hPMS2, which were purchased from Santa Cruz Biotechnology Inc., California, USA. Fluorescent signals obtained in ECL chemiluminescence system (Amersham Corp.) were visualized by exposure to X-ray ®lms. To con®rm the speci®c antigen-antibody reaction, control peptides (0.5 ± 2.5 mg/ ml) corresponding to immunized antigens were used. 
N: the most frequently observed pro®les. Vn: pro®les dierent from N, numbered.
Mutated gene-specific microsatellite instability E Oki et al to slip in a longer stretch of repeats. In fact, the rare alteration of microsatellite sequences in Drosophila cells is thought to be derived from their shortness (Schug et al., 1997) . In our system, we selected ®ve microsatellite loci with a wide range of repeat number, from 8 to 29 (Figure 4 ), and these markers detected eciently alterations in repeat sequences. To rule out the possibility that the results obtained here were derived only from dierences in repeat number in the ®ve loci in each cell line, we examined the relationship between the diversity of dinucleotide repeats and the number of repeats (Figure 4) . We used the ratio of the number of variants to the number of clones analysed as representative of the diversity of dinucleotide repeats. In HCT116 the diversity was signi®cantly higher than in SW48, despite the relative shortness of repeat stretches. Similarly, DLD-1 cells exhibited little diversity, even though the microsatellite loci had relatively long repeat stretches. Therefore, we propose that dierences of DRI among the four cell lines derived not from repeat numbers in the microsatellite loci, but rather from their genotype. We have shown that diversity of dinucleotide repeats diers by forms of mutation in MMR genes, as well as by the gene mutated. Therefore, the DRI phenotype is not only a qualitative indicator of MMR de®ciency, but also a quantitative indicator of such an abnormality. In cells, alteration of repeat sequences might re¯ect dynamics among many proteins participating in replication and repair of the genome. Using the precise and objective system that we developed (Oda et al., 1997) , the relationship between DRI phenotype and MMR gene mutation became clear. On the other hand, in this study the analysis of DRI to detect MMR-de®ciency was seen to have limits. DRI analysis is ecient to search for hMSH2 or hMLH1 mutations, but not so for hMSH6 mutation. In patients with HNPCC, over 50% have mutations in hMSH2 or hMLH1 genes (Beck et al., 1997; Liu et al., 1996) . Therefore, identifying the DRI phenotype may be an eective approach to detect the latency of HNPCC, in clinical practice. However, the method may not identify hMSH6-de®cient HNPCC patients, the existence of which was reported (Akiyama et al., 1997) . In sporadic colorectal cancers, the incidence of microsatellite instability varies between 10 and 30% (Ionov et al., 1993; Thibodeau et al., 1993) . However, the incidence of hMSH2 or hMLH1 mutation is less than a half (Herfarth et al., 1997) and in gastric and uterine cancers manifesting the DRI phenotype such mutations are rare (Kowalski et al., 1997; Wu et al., 1997a) . In this study, we did not use cell lines harbouring mutations in hMSH3, hPMS1, hPMS2 because such lines are rare. In some cancers, the DRI 
Figure 4
The relationship between CA repeat number and diversity of dinucleotide repeats. The number of CA repeat was determined in comparison with authentic sequences in the data base. Diversity of dinucleotide repeats is the ratio of the number of variants to the total number of analysed clones. (Bhattacharyya et al., 1994; Papadopoulos et al., 1995) . Further analyses may be required to de®ne both categories of DRI phenotype and MMR de®ciency. These eorts may also lead to a precise diagnosis for patients at a high risk for carcinogenesis.
